190 related articles for article (PubMed ID: 19632872)
21. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000.
Jain MK; Skiest DJ; Cloud JW; Jain CL; Burns D; Berggren RE
Clin Infect Dis; 2003 Apr; 36(8):1030-8. PubMed ID: 12684916
[TBL] [Abstract][Full Text] [Related]
22. Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment.
Català L; Orcau A; García de Olalla P; Millet JP; Rodríguez-Mondragón A; Caylà JA;
Int J Tuberc Lung Dis; 2011 Feb; 15(2):263-9, i. PubMed ID: 21219692
[TBL] [Abstract][Full Text] [Related]
23. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.
Smit C; Geskus R; Walker S; Sabin C; Coutinho R; Porter K; Prins M;
AIDS; 2006 Mar; 20(5):741-9. PubMed ID: 16514305
[TBL] [Abstract][Full Text] [Related]
24. Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011.
Lee SH; Kim KH; Lee SG; Chen DH; Jung DS; Moon CS; Park JY; Chung JS; Kwak IS; Cho GJ
J Korean Med Sci; 2013 Jan; 28(1):67-73. PubMed ID: 23341714
[TBL] [Abstract][Full Text] [Related]
25. Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil.
Pacheco AG; Tuboi SH; May SB; Moreira LF; Ramadas L; Nunes EP; Merçon M; Faulhaber JC; Harrison LH; Schechter M
J Acquir Immune Defic Syndr; 2009 Aug; 51(5):624-30. PubMed ID: 19430304
[TBL] [Abstract][Full Text] [Related]
26. [Causes of death in patients with HIV infection in two Tunisian medical centers].
Chelli J; Bellazreg F; Aouem A; Hattab Z; Mesmia H; Lasfar NB; Hachfi W; Masmoudi T; Chakroun M; Letaief A
Pan Afr Med J; 2016; 25():105. PubMed ID: 28292068
[TBL] [Abstract][Full Text] [Related]
27. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
[TBL] [Abstract][Full Text] [Related]
28. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.
Losina E; Yazdanpanah Y; Deuffic-Burban S; Wang B; Wolf LL; Messou E; Gabillard D; Seyler C; Freedberg KA; Anglaret X
Antivir Ther; 2007; 12(4):543-51. PubMed ID: 17668563
[TBL] [Abstract][Full Text] [Related]
29. [In-hospital mortality in HIV-infected patients: 10 years after the implementation of universal access to HAART in Mexico].
Martín-Onraet A; Piñeirua-Menéndez A; Perales-Martínez D; Ortega-Pérez R; Barrera-García A; Sierra-Madero J; Volkow-Fernández P
Salud Publica Mex; 2015; 57 Suppl 2():s163-70. PubMed ID: 26545132
[TBL] [Abstract][Full Text] [Related]
30. Causes of death and factors associated with early mortality of HIV-infected adults admitted to Korle-Bu Teaching Hospital.
Saavedra A; Campinha-Bacote N; Hajjar M; Kenu E; Gillani FS; Obo-Akwa A; Lartey M; Kwara A
Pan Afr Med J; 2017; 27():48. PubMed ID: 28819470
[TBL] [Abstract][Full Text] [Related]
31. AIDS-defining illnesses: a comparison between before and after commencement of highly active antiretroviral therapy (HAART).
Lian YL; Heng BS; Nissapatorn V; Lee C
Curr HIV Res; 2007 Sep; 5(5):484-9. PubMed ID: 17896968
[TBL] [Abstract][Full Text] [Related]
32. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
Dheda K; Lampe FC; Johnson MA; Lipman MC
J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
[TBL] [Abstract][Full Text] [Related]
33. Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
Komati S; Shaw PA; Stubbs N; Mathibedi MJ; Malan L; Sangweni P; Metcalf JA; Masur H; Hassim S
AIDS; 2010 Jul; 24(12):1849-55. PubMed ID: 20622529
[TBL] [Abstract][Full Text] [Related]
34. Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries.
Llibre JM; Revollo B; Vanegas S; Lopez-Nuñez JJ; Ornelas A; Marin JM; Santos JR; Marte P; Morera M; Zuluaga P; Tor J; Clotet B
Scand J Infect Dis; 2013 Aug; 45(8):635-44. PubMed ID: 23547568
[TBL] [Abstract][Full Text] [Related]
35. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
[TBL] [Abstract][Full Text] [Related]
36. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
37. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003.
Radhi S; Alexander T; Ukwu M; Saleh S; Morris A
BMC Infect Dis; 2008 Sep; 8():118. PubMed ID: 18796158
[TBL] [Abstract][Full Text] [Related]
38. [Opportunistic episodes in patients infected with the human immunodeficiency virus during the first 6 months of HAART].
González-Castillo J; Blanco F; Soriano V; Barreiro P; Concepción Bravo M; Jiménez-Nácher I; González-Lahoz J
Med Clin (Barc); 2001 Jun; 117(3):81-4. PubMed ID: 11459574
[TBL] [Abstract][Full Text] [Related]
39. A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?
Kiragga AN; Mubiru F; Kambugu AD; Kamya MR; Castelnuovo B
BMC Infect Dis; 2019 Jan; 19(1):77. PubMed ID: 30665434
[TBL] [Abstract][Full Text] [Related]
40. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.
Jordano Q; Falcó V; Almirante B; Planes AM; del Valle O; Ribera E; Len O; Pigrau C; Pahissa A
Clin Infect Dis; 2004 Jun; 38(11):1623-8. PubMed ID: 15156452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
